12 results
10-K
2021 FY
IOBT
IO Biotech Inc
31 Mar 22
Annual report
5:07pm
in criminal prosecution, fines or other penalties, injunctions, exclusion from federal healthcare programs, requests for recall, seizure of products … to our sales and manufacturing arrangements; (ii) additions or modifications to product labeling or packaging; (iii) the recall or discontinuation of our
10-Q
2021 Q3
IOBT
IO Biotech Inc
17 Dec 21
Quarterly report
4:55pm
, and even recall or market withdrawal if unanticipated safety issues are discovered following approval. In addition, we may be subject to penalties or other … by requiring, for example: (i) changes to our manufacturing arrangements; (ii) additions or modifications to product labeling; (iii) the recall
8-K
EX-10.1
IOBT
IO Biotech Inc
6 Dec 21
Entry into a Material Definitive Agreement
9:00am
for Manufacturing sites; and (vi) include provisions governing the recall of Compounds. Quality matters and the Manufacture of the MSD Compound shall
424B4
2q1la4p9iazm2496k
8 Nov 21
Prospectus supplement with pricing info
5:20pm
S-1/A
EX-10.12
52v14n
26 Oct 21
IPO registration (amended)
5:15pm
S-1
ufc0i9adm tej2ifxj6v
15 Oct 21
IPO registration
5:18pm
DRS/A
yfrybpt9
6 Oct 21
Draft registration statement (amended)
12:00am
DRS/A
xduia
9 Aug 21
Draft registration statement (amended)
12:00am
DRS
6hu3y8ayr4uhqc9
3 Jun 21
Draft registration statement
12:00am
- Prev
- 1
- Next